Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no substantive content changes observed in the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:27:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, which warned that updates might not be current and that responses could be delayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:50:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No significant changes were detected; the page content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T20:38:52.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updated site notice about funding-related operating status and a new v3.2.0 release; removed the previous v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-06T04:34:54.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T01:19:39.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version bump from v3.0.1 to v3.0.2 and removal of the Back to Top control; overall, a minor update with no substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-14T18:47:50.000Z thumbnail image

Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.